BRANMOOR
THURSDAY · 14 MAY 2026

FDA Device Recall Z-1767-2025

Baxter Healthcare Corporation · Deerfield, IL

Class I — life-threatening Ongoing

Highest impact — Class I device recall — FDA determination that use of, or exposure to, the device will cause serious adverse health consequences or death.

Device

Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS

Lot / serial / GTIN: All serial numbers

Quantity: 34,524 units

Reason for recall

There is a potential for the Novum IQ LVP due to the potential for underinfusion following use of the "standby mode" feature or if the device is powered off with the set loaded.

Recall record

Recall number
Z-1767-2025
Classification
Class I
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
US and Canada
Recall initiated
2025-04-24
Classified by FDA Center
2025-05-20
FDA published
2025-05-28
Recalling firm
Baxter Healthcare Corporation
Firm location
Deerfield, IL

Operational response

A Class I device recall indicates a strong likelihood of serious adverse health consequence or death from continued use. Identify affected units by serial number, lot, or GTIN against your inventory and against implanted-device patient registry. Pull affected inventory from active use immediately. For implanted devices, follow the recalling firm’s patient-notification protocol; in most cases this requires informing affected patients and their treating physicians directly.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All device recalls